Selexys Pharmaceuticals

Selexys Pharmaceuticals is a biopharmaceutical company focused on developing therapies for inflammation, thrombosis, and the metastasis of a wide range of severe diseases. It is also developing an antibody targeting PSGL-1 for the treatment of Crohn's disease, multiple myeloma, and other inflammatory conditions.